Forecasts data is unavailable for this security.
Consensus recommendation
- 14-Sep-23
- 20-Jun-24
- 18-Jul-24
- 15-Aug-24
- 12-Sep-24
Select bar for recommendation details.
Recommendations | 12-Sep-24 | |
---|---|---|
Buy | 7 | |
Outperform | 14 | |
Hold | 7 | |
Sell | 0 | |
Strong Sell | 0 |
Share price forecast in USD
The 24 analysts offering 12 month price targets for Biomarin Pharmaceutical Inc have a median target of 105.50, with a high estimate of 139.00 and a low estimate of 72.00. The median estimate represents a 48.30% increase from the last price of 71.14.
High | 95.4% | 139.00 |
Med | 48.3% | 105.50 |
Low | 1.2% | 72.00 |
Earnings history & estimates in USD
The next earnings announcement is expected on Oct 30, 2024.
Average growth rate | +65.64% |
Average growth rate | +16.00% |
More ▼
Revenue history & estimates in USD
Average growth rate | +4.74% |
Average growth rate | +9.34% |
More ▼